In breast cancer cells, MDM2 overexpression or p53 KD reduced OVOL2 protein expression, and the proteasome inhibitor MG132 blocked the MDM2 overexpression‐ or p53 KD‐mediated reduction in OVOL2 expression (Figure 6B,C). This evidence concerns the gene OVOL2 and breast carcinoma.